These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24326546)

  • 1. Toward T cell protein-protein interaction activity relevant to alopecia areata.
    Neier SC; Smith SE; Davis TR; Gil D; Schrum AG
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S31-3. PubMed ID: 24326546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine pathways and interactions in alopecia areata.
    Giordano CN; Sinha AA
    Eur J Dermatol; 2013; 23(3):308-18. PubMed ID: 23797621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of alopecia areata: "What is new on the horizon?".
    Hordinsky MK
    Dermatol Ther; 2011; 24(3):364-8. PubMed ID: 21689246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia areata: a review of disease pathogenesis.
    Rajabi F; Drake LA; Senna MM; Rezaei N
    Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
    Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
    J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Changing Landscape of Alopecia Areata: The Translational Landscape.
    Wang ECE; Christiano AM
    Adv Ther; 2017 Jul; 34(7):1586-1593. PubMed ID: 28646392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lymphocytes in the development and treatment of alopecia areata.
    Guo H; Cheng Y; Shapiro J; McElwee K
    Expert Rev Clin Immunol; 2015; 11(12):1335-51. PubMed ID: 26548356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Alopecia Areata with Simvastatin/Ezetimibe.
    Cervantes J; Jimenez JJ; DelCanto GM; Tosti A
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S25-S31. PubMed ID: 29273101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Changing Landscape of Alopecia Areata: An Introduction.
    Han G
    Adv Ther; 2017 Jul; 34(7):1584-1585. PubMed ID: 28646391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of AA and Research Progress: What Have We Learned and Where Are We Headed?
    Norris DA
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):6-8. PubMed ID: 26551935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata.
    Ito T; Tokura Y
    Exp Dermatol; 2014 Nov; 23(11):787-91. PubMed ID: 25040075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation.
    Brown EA; Neier SC; Neuhauser C; Schrum AG; Smith SEP
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31498315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populations.
    Czarnowicki T; He HY; Wen HC; Hashim PW; Nia JK; Malik K; Estrada Y; Kimmel GW; Taliercio M; Krueger JG; Guttman-Yassky E
    Allergy; 2018 Mar; 73(3):713-723. PubMed ID: 29083474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
    Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
    Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
    Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3 Gallate Inhibits
    Hamed FN; McDonagh AJG; Almaghrabi S; Bakri Y; Messenger AG; Tazi-Ahnini R
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30558329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation.
    Fiedler-Weiss VC; Buys CM
    Br J Dermatol; 1987 Dec; 117(6):759-63. PubMed ID: 3501310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapies for alopecia areata: The era of rational drug development.
    Wang ECE; Dai Z; Christiano AM
    J Allergy Clin Immunol; 2018 Feb; 141(2):499-504. PubMed ID: 29155099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.
    McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M
    J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.